HEALTHEQUITY, Inc. (HQY) intrinsic value & 10-year financials

HEALTHEQUITY, Inc. (HQY) has a Graham intrinsic value of $81.71 per share. At $92.03 on Oct 17, 2026, the stock trades 13% above that value. Over the last 10 fiscal years revenue grew 24.8% a year to $1.3B, with an average return on invested capital of 11.7%.

Graham intrinsic value
$81.71
Share price (Oct 17, 2026)
$92.03
Price vs Graham value
13% above
Market cap
$8.1B
Revenue (FY2026)
$1.3B
Revenue growth (10-yr CAGR)
24.8%
ROIC (10-yr avg)
11.7%
Free cash flow (FY2026)
$455.1M

HQY 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2026 $1.3B $215.2M $2.46 $455.1M 24.6% 8.8%
FY2025 $1.2B $96.7M $1.09 $337.8M 13.5% 4.9%
FY2024 $999.6M $55.7M $0.64 $241.1M 11.8% 3.4%
FY2023 $861.7M -$26.1M -$0.31 $147.3M 1.1% 0.2%
FY2022 $756.6M -$44.3M -$0.53 $132.1M -3.2% -0.7%
FY2021 $733.6M $8.8M $0.12 $168.5M 4.6% 1.6%
FY2020 $532.0M $39.7M $0.58 $97.7M 14.5% 6.3%
FY2019 $287.2M $73.9M $1.17 $109.6M 27.0% 65.5%
FY2018 $229.5M $47.4M $0.77 $76.2M 23.7% 16.2%
FY2017 $178.4M $26.4M $0.44 $41.9M 23.1% 10.3%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

HEALTHEQUITY, INC. is a consistent compounder, expanding top-line revenue at 24.8% annually over the past decade.

HEALTHEQUITY, INC. returns on capital have been average, hovering around 11.7% ROIC over the decade.

HEALTHEQUITY, INC. has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, HEALTHEQUITY, INC. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $81.71 per share.

HQY stock: frequently asked questions

What is the intrinsic value of HEALTHEQUITY, Inc. (HQY) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 15.0% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, HQY's intrinsic value is about $81.71 per share.

Is HQY stock undervalued?

At $92.03 (close on Oct 17, 2026), HQY trades 13% above its Graham value of $81.71. On Graham's terms the shares look fully priced. A formula is a starting point for research, not a recommendation.

How fast has HEALTHEQUITY, Inc. grown?

Revenue went from $178.4M in fiscal 2017 to $1.3B in fiscal 2026, a compound annual growth rate of 24.8%. Net income was $215.2M in fiscal 2026.

Does HEALTHEQUITY, Inc. generate free cash flow?

HEALTHEQUITY, Inc. generated $455.1M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2026. Free cash flow was positive in 10 of the last 10 reported years.

What is HQY's return on invested capital?

Average ROIC over the last 10 fiscal years was 11.7%, and average return on equity was 6.3%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this HQY data come from?

From HEALTHEQUITY, Inc.'s annual 10-K filings on SEC EDGAR, most recently filed May 28, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar business services stocks